SCHEMBL2465614

SCHEMBL2465614

COc1cc(CC#Cc2ccccc2)cc(OC)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.46
MAPK1 P28482 1/20 0.46
DHFR P00374 2/20 0.44
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
THPO P40225 1/20 0.42
MAOB P27338 1/20 0.42
FFAR1 O14842 1/20 0.41
BLM P54132 1/20 0.41
PMP22 Q01453 1/20 0.41
ABCB1 P08183 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
HTR2A P28223 1/20 0.41
SIGMAR1 Q99720 1/20 0.40
LTA4H P09960 1/20 0.40
CA4 P22748 1/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21244052 0.84 LTA4H (0.55) TSHRCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL2462940 0.81 HTR2A (0.45) CYP1A2CYP3A4CYP2C9CYP2C19THPO
SCHEMBL702843 0.80 LTA4H (0.55) TSHRCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL5966253 0.79 DHFR (0.48) DHFRABCB1ALDH1A1MAPTHTR2A
SCHEMBL28074286 0.79 APP (0.52) CYP1A2CYP3A4CYP2C9CYP2C19FFAR1
SCHEMBL9578471 0.74 GAA (0.46) TSHRCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL28811444 0.74 APP (0.50) TSHRCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL3397750 0.74 CYP1A2 (0.58) CYP1A2CYP3A4CYP2C9CYP2C19THPO
SCHEMBL13332739 0.72 MAOB (0.70) MAOBABCB1
SCHEMBL20091151 0.71 L3MBTL1 (0.47) CYP1A2CYP3A4CYP2C9CYP2C19THPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011119778-A2 METHOD FOR IN-SITU FORMATION OF METATHESIS CATALYSTS SCHRODI YANN (US) 2011-09-29 WO disclosed